{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:58:02Z","timestamp":1781233082511,"version":"3.54.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Obes Rep"],"DOI":"10.1007\/s13679-026-00729-0","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:48:03Z","timestamp":1781232483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Demystifying Nutritional Consequences of Pharmacological Weight Loss and Performance Enhancement-A Critical Narrative Review"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5442-5811","authenticated-orcid":false,"given":"Richa","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0165-0294","authenticated-orcid":false,"given":"Dweipayan","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3978-5277","authenticated-orcid":false,"given":"Adil","family":"Gani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0293-1891","authenticated-orcid":false,"given":"Prakash M.","family":"Halami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"729_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s13679-023-00534-z","volume":"12","author":"TA Wadden","year":"2023","unstructured":"Wadden TA, Chao AM, Moore M, Tronieri JS, Gilden A, Amaro A, et al. The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities. Curr Obes Rep. 2023;12:453\u201373. https:\/\/doi.org\/10.1007\/s13679-023-00534-z.","journal-title":"Curr Obes Rep"},{"key":"729_CR2","doi-asserted-by":"publisher","first-page":"e194744","DOI":"10.1172\/JCI194744","volume":"136","author":"LR Beutler","year":"2026","unstructured":"Beutler LR. GLP-1 physiology and pharmacology along the gut-brain axis. J Clin Invest. 2026;136:e194744. https:\/\/doi.org\/10.1172\/JCI194744.","journal-title":"J Clin Invest"},{"key":"729_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev-pharmtox-031124-101146","volume":"65","author":"AM Chao","year":"2025","unstructured":"Chao AM, Taylor S, Moore M, Amaro A, Wadden TA. Evolving Approaches for Pharmacological Therapy of Obesity. Annu Rev Pharmacol Toxicol. 2025;65:169\u201389. https:\/\/doi.org\/10.1146\/annurev-pharmtox-031124-101146.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"729_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/oby.22642","volume":"28","author":"RF Kushner","year":"2020","unstructured":"Kushner RF, Batsis JA, Butsch WS, Davis N, Golden A, Halperin F, et al. Weight History in Clinical Practice: The State of the Science and Future Directions. Obesity. 2020;28:9\u201317. https:\/\/doi.org\/10.1002\/oby.22642.","journal-title":"Obesity"},{"key":"729_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1210\/er.2013-1058","volume":"35","author":"HG Pope","year":"2014","unstructured":"Pope HG, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement. Endocr Rev. 2014;35:341\u201375. https:\/\/doi.org\/10.1210\/er.2013-1058.","journal-title":"Endocr Rev"},{"key":"729_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00210-025-04403-5","volume":"399","author":"LE Propfe","year":"2026","unstructured":"Propfe LE, Seifert R. Misrepresentation of semaglutide in social media. Naunyn Schmiedebergs Arch Pharmacol. 2026;399:815\u201332. https:\/\/doi.org\/10.1007\/s00210-025-04403-5.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"729_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.clindermatol.2023.03.002","volume":"41","author":"MR Laughter","year":"2023","unstructured":"Laughter MR, Anderson JB, Maymone MBC, Kroumpouzos G. Psychology of aesthetics: Beauty, social media, and body dysmorphic disorder. Clin Dermatol. 2023;41:28\u201332. https:\/\/doi.org\/10.1016\/j.clindermatol.2023.03.002.","journal-title":"Clin Dermatol"},{"key":"729_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/rp.56.1.309","volume":"56","author":"S Collins","year":"2001","unstructured":"Collins S. The Beta-Adrenergic Receptors and the Control of Adipose Tissue Metabolism and Thermogenesis. Recent Prog Horm Res. 2001;56:309\u201328. https:\/\/doi.org\/10.1210\/rp.56.1.309.","journal-title":"Recent Prog Horm Res"},{"key":"729_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev.nutr.20.1.365","volume":"20","author":"C Holm","year":"2000","unstructured":"Holm C, \u00d8sterlund T, Laurell H, Contreras JA. Molecular Mechanisms Regulating Hormone-Sensitive Lipase and Lipolysis. Annu Rev Nutr. 2000;20:365\u201393. https:\/\/doi.org\/10.1146\/annurev.nutr.20.1.365.","journal-title":"Annu Rev Nutr"},{"key":"729_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgae719","volume":"110","author":"RJ Jalleh","year":"2024","unstructured":"Jalleh RJ, Plummer MP, Marathe CS, Umapathysivam MM, Quast DR, Rayner CK, et al. Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. J Clin Endocrinol Metab. 2024;110:1\u201315. https:\/\/doi.org\/10.1210\/clinem\/dgae719.","journal-title":"J Clin Endocrinol Metab"},{"key":"729_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/jama.2023.24945","volume":"331","author":"LJ Aronne","year":"2024","unstructured":"Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin W-Y, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331:38. https:\/\/doi.org\/10.1001\/jama.2023.24945.","journal-title":"JAMA"},{"key":"729_CR12","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","volume":"28","author":"WT Garvey","year":"2022","unstructured":"Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28:2083\u201391. https:\/\/doi.org\/10.1038\/s41591-022-02026-4.","journal-title":"Nat Med"},{"key":"729_CR13","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989\u20131002. https:\/\/doi.org\/10.1056\/NEJMoa2032183.","journal-title":"N Engl J Med"},{"key":"729_CR14","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.3390\/ijms22052596","volume":"22","author":"H Kaneto","year":"2021","unstructured":"Kaneto H, Kimura T, Obata A, Shimoda M, Kaku K. Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History. Int J Mol Sci. 2021;22:2596. https:\/\/doi.org\/10.3390\/ijms22052596.","journal-title":"Int J Mol Sci"},{"key":"729_CR15","doi-asserted-by":"publisher","unstructured":"Mantri S, Agarwal S, Jaiswal A, Yelne S, Prasad R, Wanjari MB, Bodybuilding. A Comprehensive Review of Performance-Enhancing Substance Use and Public Health Implications. Cureus. 2023 https:\/\/doi.org\/10.7759\/cureus.41600. [cited 2026 Apr 2].","DOI":"10.7759\/cureus.41600"},{"key":"729_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.scispo.2016.12.001","volume":"32","author":"A Ostovar","year":"2017","unstructured":"Ostovar A, Haerinejad MJ, Farzaneh MR, Keshavarz M. Adverse effects of performance-enhancing drugs on the kidney in the male bodybuilders. Sci Sports. 2017;32:91\u20138. https:\/\/doi.org\/10.1016\/j.scispo.2016.12.001.","journal-title":"Sci Sports"},{"key":"729_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/1741659006061711","volume":"2","author":"P Manning","year":"2006","unstructured":"Manning P. There\u2019s no glamour in glue: News and the symbolic framing of substance misuse. Crime Media Cult Int J. 2006;2:49\u201366. https:\/\/doi.org\/10.1177\/1741659006061711.","journal-title":"Crime Media Cult Int J"},{"key":"729_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5152\/ClinSciNutr.2020.962","volume":"1","author":"N Yal\u00e7\u0131n","year":"2020","unstructured":"Yal\u00e7\u0131n N, Armut M, Kelleci \u00c7ak\u0131r B, Demirkan K. Drug-induced nutritional disorders. Clin Sci Nutr. 2020;1:113\u201322. https:\/\/doi.org\/10.5152\/ClinSciNutr.2020.962.","journal-title":"Clin Sci Nutr"},{"key":"729_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopen.2016.10.001","volume":"4","author":"FD Desgorces","year":"2017","unstructured":"Desgorces FD, Moinard C, Chennaoui M, Toussaint J-F, Petibois C, Noirez P. Development of a specific index to detect malnutrition in athletes: Validity in weight class or intermittent fasted athletes. Biochim Open. 2017;4:1\u20137. https:\/\/doi.org\/10.1016\/j.biopen.2016.10.001.","journal-title":"Biochim Open"},{"key":"729_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/thy.2007.0252","volume":"18","author":"JE Silva","year":"2008","unstructured":"Silva JE, Bianco SDC. Thyroid\u2013Adrenergic Interactions: Physiological and Clinical Implications. Thyroid. 2008;18:157\u201365. https:\/\/doi.org\/10.1089\/thy.2007.0252.","journal-title":"Thyroid"},{"key":"729_CR21","doi-asserted-by":"publisher","first-page":"e12880","DOI":"10.1111\/acel.12880","volume":"18","author":"AR Konopka","year":"2019","unstructured":"Konopka AR, Laurin JL, Schoenberg HM, Reid JJ, Castor WM, Wolff CA, et al. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell. 2019;18:e12880. https:\/\/doi.org\/10.1111\/acel.12880.","journal-title":"Aging Cell"},{"key":"729_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrendo.2014.91","volume":"10","author":"S Murray","year":"2014","unstructured":"Murray S, Tulloch A, Gold MS, Avena NM. Hormonal and neural mechanisms of food reward, eating behaviour and obesity. Nat Rev Endocrinol. 2014;10:540\u201352. https:\/\/doi.org\/10.1038\/nrendo.2014.91.","journal-title":"Nat Rev Endocrinol"},{"key":"729_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3945\/jn.108.097618","volume":"139","author":"M Lutter","year":"2009","unstructured":"Lutter M, Nestler EJ. Homeostatic and Hedonic Signals Interact in the Regulation of Food Intake. J Nutr. 2009;139:629\u201332. https:\/\/doi.org\/10.3945\/jn.108.097618.","journal-title":"J Nutr"},{"key":"729_CR24","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","volume":"11","author":"A Kalender","year":"2010","unstructured":"Kalender A, Selvaraj A, Kim SY, Gulati P, Br\u00fbl\u00e9 S, Viollet B, et al. Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner. Cell Metab. 2010;11:390\u2013401. https:\/\/doi.org\/10.1016\/j.cmet.2010.03.014.","journal-title":"Cell Metab"},{"key":"729_CR25","doi-asserted-by":"publisher","first-page":"e13039","DOI":"10.1111\/acel.13039","volume":"18","author":"RG Walton","year":"2019","unstructured":"Walton RG, Dungan CM, Long DE, Tuggle SC, Kosmac K, Peck BD, et al. Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo\u2010controlled, multicenter trial: The MASTERS trial. Aging Cell. 2019;18:e13039. https:\/\/doi.org\/10.1111\/acel.13039.","journal-title":"Aging Cell"},{"key":"729_CR26","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1113\/JP275560","volume":"596","author":"M Hostrup","year":"2018","unstructured":"Hostrup M, Reitelseder S, Jessen S, Kalsen A, Nyberg M, Egelund J, et al. Beta2 -adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men. J Physiol. 2018;596:4121\u201339. https:\/\/doi.org\/10.1113\/JP275560.","journal-title":"J Physiol"},{"key":"729_CR27","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/JOE-17-0166","volume":"235","author":"A Stojakovic","year":"2017","unstructured":"Stojakovic A, Espinosa EP, Farhad OT, Lutfy K. Effects of nicotine on homeostatic and hedonic components of food intake. J Endocrinol. 2017;235:R13\u201331. https:\/\/doi.org\/10.1530\/JOE-17-0166.","journal-title":"J Endocrinol"},{"key":"729_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/jcdd12040112","volume":"12","author":"YF Bella","year":"2025","unstructured":"Bella YF, Cupido SRS, Inacio PAQ, Sobral MLP, Vieira RP. Pre-Workout Supplements and Their Effects on Cardiovascular Health: An Integrative Review. J Cardiovasc Dev Dis. 2025;12:112. https:\/\/doi.org\/10.3390\/jcdd12040112.","journal-title":"J Cardiovasc Dev Dis"},{"key":"729_CR29","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/oby.24336","volume":"33","author":"D Mozaffarian","year":"2025","unstructured":"Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, et al. Nutritional priorities to support GLP -1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity. 2025;33:1475\u2013503. https:\/\/doi.org\/10.1002\/oby.24336.","journal-title":"Obesity"},{"key":"729_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41366-025-01952-w","volume":"50","author":"M Spreckley","year":"2026","unstructured":"Spreckley M, Ruggiero CF, Brown A. Bridging the nutrition guidance gap for GLP-1 receptor agonist therapy assisted weight loss: lessons from bariatric surgery. Int J Obes. 2026;50:265\u20137. https:\/\/doi.org\/10.1038\/s41366-025-01952-w.","journal-title":"Int J Obes"},{"key":"729_CR31","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1161\/CIRCULATIONAHA.124.067676","volume":"150","author":"J Linge","year":"2024","unstructured":"Linge J, Birkenfeld AL, Neeland IJ. Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss? Circulation. 2024;150:1288\u201398. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.067676.","journal-title":"Circulation"},{"key":"729_CR32","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.2337\/dci23-0100","volume":"47","author":"JC Locatelli","year":"2024","unstructured":"Locatelli JC, Costa JG, Haynes A, Naylor LH, Fegan PG, Yeap BB, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition? Diabetes Care. 2024;47:1718\u201330. https:\/\/doi.org\/10.2337\/dci23-0100.","journal-title":"Diabetes Care"},{"key":"729_CR33","doi-asserted-by":"publisher","first-page":"118731","DOI":"10.1016\/j.biopha.2025.118731","volume":"193","author":"SA Fahim","year":"2025","unstructured":"Fahim SA, Attia YM, Messiha A, Nabawy AY, Refaat F, El-Maadawy WH. Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management. Biomed Pharmacother. 2025;193:118731. https:\/\/doi.org\/10.1016\/j.biopha.2025.118731.","journal-title":"Biomed Pharmacother"},{"key":"729_CR34","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","volume":"397","author":"M Davies","year":"2021","unstructured":"Davies M, F\u00e6rch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, et al. Semaglutide 2\u00b74\u00a0mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021;397:971\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(21)00213-0.","journal-title":"Lancet"},{"key":"729_CR35","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/jamasurg.2024.0111","volume":"159","author":"S Sen","year":"2024","unstructured":"Sen S, Potnuru PP, Hernandez N, Goehl C, Praestholm C, Sridhar S, et al. Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia. JAMA Surg. 2024;159:660. https:\/\/doi.org\/10.1001\/jamasurg.2024.0111.","journal-title":"JAMA Surg"},{"key":"729_CR36","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1001\/jama.2021.1831","volume":"325","author":"TA Wadden","year":"2021","unstructured":"Wadden TA, Bailey TS, Billings LK, Davies M, Frias JP, Koroleva A, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021;325:1403. https:\/\/doi.org\/10.1001\/jama.2021.1831.","journal-title":"JAMA"},{"key":"729_CR37","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jama.2024.9217","volume":"332","author":"L Zhao","year":"2024","unstructured":"Zhao L, Cheng Z, Lu Y, Liu M, Chen H, Zhang M, et al. Tirzepatide for Weight Reduction in Chinese Adults With Obesity: The SURMOUNT-CN Randomized Clinical Trial. JAMA. 2024;332:551. https:\/\/doi.org\/10.1001\/jama.2024.9217.","journal-title":"JAMA"},{"key":"729_CR38","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/jama.2021.3224","volume":"325","author":"D Rubino","year":"2021","unstructured":"Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325:1414. https:\/\/doi.org\/10.1001\/jama.2021.3224.","journal-title":"JAMA"},{"key":"729_CR39","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/dom.14725","volume":"24","author":"JPH Wilding","year":"2022","unstructured":"Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24:1553\u201364. https:\/\/doi.org\/10.1111\/dom.14725.","journal-title":"Diabetes Obes Metab"},{"key":"729_CR40","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/jac5.1999","volume":"7","author":"A Spitery","year":"2024","unstructured":"Spitery A, Elder MJ, Farhat N, Mohammad I, Lobkovich A. Legal, safety, and practical considerations of compounded injectable semaglutide. JACCP J Am Coll Clin Pharm. 2024;7:941\u20136. https:\/\/doi.org\/10.1002\/jac5.1999.","journal-title":"JACCP J Am Coll Clin Pharm"},{"key":"729_CR41","doi-asserted-by":"publisher","first-page":"100355","DOI":"10.1016\/j.peh.2025.100355","volume":"14","author":"LA Turnock","year":"2026","unstructured":"Turnock LA, Germain J, Hirst M, Hearne E, Off-label, Semaglutide. GLP-1 weight-loss medicine use for anti-ageing: A Netnography of older bodybuilders\u2019 experiences and understandings. Perform Enhanc Health. 2026;14:100355. https:\/\/doi.org\/10.1016\/j.peh.2025.100355.","journal-title":"Perform Enhanc Health"},{"key":"729_CR42","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1038\/s41598-026-38495-7","volume":"16","author":"AD Grant","year":"2026","unstructured":"Grant AD, Erfe MCB, Kazaryan A, Oliver PL, Moos J, Luna V, et al. A novel fasting mimetic (Mimio) creates fasting-like benefits to hunger control, oxidative stress, and cardiometabolic health in humans. Sci Rep. 2026;16:7812. https:\/\/doi.org\/10.1038\/s41598-026-38495-7.","journal-title":"Sci Rep"},{"key":"729_CR43","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41574-024-00992-y","volume":"20","author":"HT Langer","year":"2024","unstructured":"Langer HT, Rohm M, Goncalves MD, Sylow L. AMPK as a mediator of tissue preservation: time for a shift in dogma? Nat Rev Endocrinol. 2024;20:526\u201340. https:\/\/doi.org\/10.1038\/s41574-024-00992-y.","journal-title":"Nat Rev Endocrinol"},{"key":"729_CR44","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s42255-025-01254-5","volume":"7","author":"MP Mattson","year":"2025","unstructured":"Mattson MP. The cyclic metabolic switching theory of intermittent fasting. Nat Metab. 2025;7:665\u201378. https:\/\/doi.org\/10.1038\/s42255-025-01254-5.","journal-title":"Nat Metab"},{"key":"729_CR45","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/jcsm.12833","volume":"13","author":"MJ Kang","year":"2022","unstructured":"Kang MJ, Moon JW, Lee JO, Kim JH, Jung EJ, Kim SJ, et al. Metformin induces muscle atrophy by transcriptional regulation of myostatin via HDAC6 and FoxO3a. J Cachexia Sarcopenia Muscle. 2022;13:605\u201320. https:\/\/doi.org\/10.1002\/jcsm.12833.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"729_CR46","doi-asserted-by":"publisher","first-page":"916","DOI":"10.4239\/wjd.v12.i7.916","volume":"12","author":"M Infante","year":"2021","unstructured":"Infante M, Leoni M, Caprio M, Fabbri A. Long-term metformin therapy and vitamin B12 deficiency: an association to bear in mind. World J Diabetes. 2021;12:916\u201331. https:\/\/doi.org\/10.4239\/wjd.v12.i7.916.","journal-title":"World J Diabetes"},{"key":"729_CR47","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i7.107514","author":"M Alvarez","year":"2025","unstructured":"Alvarez M, Prieto AE, Portilla N, Moya D, Rincon O, Guzman I. Metformin-induced vitamin B12 deficiency: An underdiagnosed cause of diabetic neuropathy. World J Diabetes [Internet]. 2025. https:\/\/doi.org\/10.4239\/wjd.v16.i7.107514. [cited 2026 Apr 2];16.","journal-title":"World J Diabetes [Internet]"},{"key":"729_CR48","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tem.2024.07.017","volume":"36","author":"L Yao","year":"2025","unstructured":"Yao L, Wang L, Zhang R, Soukas AA, Wu L. The direct targets of metformin in diabetes and beyond. Trends Endocrinol Metab. 2025;36:364\u201372. https:\/\/doi.org\/10.1016\/j.tem.2024.07.017.","journal-title":"Trends Endocrinol Metab"},{"key":"729_CR49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1055\/a-1608-0345","volume":"130","author":"L Gao","year":"2022","unstructured":"Gao L, Huang H, Zhang L, Zhang N, Fu Y, Zhu D, et al. Comparison of Beinaglutide Versus Metformin for Weight Loss in Overweight and Obese Non-diabetic Patients. Exp Clin Endocrinol Diabetes. 2022;130:358\u201367. https:\/\/doi.org\/10.1055\/a-1608-0345.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"729_CR50","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s00508-017-1251-6","volume":"129","author":"V Schwetz","year":"2017","unstructured":"Schwetz V, Eisner F, Schilcher G, Eller K, Plank J, Lind A, et al. Combined metformin-associated lactic acidosis and euglycemic ketoacidosis. Wien Klin Wochenschr. 2017;129:646\u20139. https:\/\/doi.org\/10.1007\/s00508-017-1251-6.","journal-title":"Wien Klin Wochenschr"},{"key":"729_CR51","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s40279-022-01801-0","volume":"53","author":"JM Smoliga","year":"2023","unstructured":"Smoliga JM, Wilber ZT, Robinson BT. Premature Death in Bodybuilders: What Do We Know? Sports Med. 2023;53:933\u201348. https:\/\/doi.org\/10.1007\/s40279-022-01801-0.","journal-title":"Sports Med"},{"key":"729_CR52","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jccase.2013.07.004","volume":"8","author":"AR Barry","year":"2013","unstructured":"Barry AR, Graham MM. Case report and review of clenbuterol cardiac toxicity. J Cardiol Cases. 2013;8:131\u20133. https:\/\/doi.org\/10.1016\/j.jccase.2013.07.004.","journal-title":"J Cardiol Cases"},{"key":"729_CR53","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/08897077.2013.772083","volume":"34","author":"HA Spiller","year":"2013","unstructured":"Spiller HA, James KJ, Scholzen S, Borys DJ. A Descriptive Study of Adverse Events from Clenbuterol Misuse and Abuse for Weight Loss and Bodybuilding. Subst Abuse. 2013;34:306\u201312. https:\/\/doi.org\/10.1080\/08897077.2013.772083.","journal-title":"Subst Abuse"},{"key":"729_CR54","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1126\/science.1201889","volume":"332","author":"YS Mineur","year":"2011","unstructured":"Mineur YS, Abizaid A, Rao Y, Salas R, DiLeone RJ, G\u00fcndisch D, et al. Nicotine Decreases Food Intake Through Activation of POMC Neurons. Science. 2011;332:1330\u20132. https:\/\/doi.org\/10.1126\/science.1201889.","journal-title":"Science"},{"key":"729_CR55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/rp.56.1.309","volume":"56","author":"S Collins","year":"2001","unstructured":"Collins S. The -Adrenergic Receptors and the Control of Adipose Tissue Metabolism and Thermogenesis. Recent Prog Horm Res. 2001;56:309\u201328. https:\/\/doi.org\/10.1210\/rp.56.1.309.","journal-title":"Recent Prog Horm Res"},{"key":"729_CR56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/nutrit\/nuy001","volume":"76","author":"B Murray","year":"2018","unstructured":"Murray B, Rosenbloom C. Fundamentals of glycogen metabolism for coaches and athletes. Nutr Rev. 2018;76:243\u201359. https:\/\/doi.org\/10.1093\/nutrit\/nuy001.","journal-title":"Nutr Rev"},{"key":"729_CR57","doi-asserted-by":"publisher","unstructured":"Mountjoy M, Ackerman KE, Bailey DM, Burke LM, Constantini N, Hackney AC et al. International Olympic Committee\u2019s (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). Br J Sports Med. 2023;57:1073\u201398. https:\/\/doi.org\/10.1136\/bjsports-2023-106994","DOI":"10.1136\/bjsports-2023-106994"},{"key":"729_CR58","doi-asserted-by":"publisher","first-page":"e14327","DOI":"10.1111\/sms.14327","volume":"34","author":"AK Melin","year":"2024","unstructured":"Melin AK, Areta JL, Heikura IA, Stellingwerff T, Torstveit MK, Hackney AC. Direct and indirect impact of low energy availability on sports performance. Scand J Med Sci Sports. 2024;34:e14327. https:\/\/doi.org\/10.1111\/sms.14327.","journal-title":"Scand J Med Sci Sports"},{"key":"729_CR59","doi-asserted-by":"publisher","first-page":"103250","DOI":"10.1016\/j.redox.2024.103250","volume":"75","author":"JS Jeppesen","year":"2024","unstructured":"Jeppesen JS, Caldwell HG, Lossius LO, Melin AK, Gliemann L, Bangsbo J, et al. Low energy availability increases immune cell formation of reactive oxygen species and impairs exercise performance in female endurance athletes. Redox Biol. 2024;75:103250. https:\/\/doi.org\/10.1016\/j.redox.2024.103250.","journal-title":"Redox Biol"},{"key":"729_CR60","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40279-024-02130-0","volume":"55","author":"TL Gallant","year":"2025","unstructured":"Gallant TL, Ong LF, Wong L, Sparks M, Wilson E, Puglisi JL, et al. Low Energy Availability and Relative Energy Deficiency in Sport: A Systematic Review and Meta-analysis. Sports Med. 2025;55:325\u201339. https:\/\/doi.org\/10.1007\/s40279-024-02130-0.","journal-title":"Sports Med"},{"key":"729_CR61","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1139\/apnm-2024-0037","volume":"49","author":"A Sim","year":"2024","unstructured":"Sim A, Tan HQ, Ali Y, Burns SF. Original investigation: manipulating energy availability in male endurance runners: a randomised controlled trial. Appl Physiol Nutr Metab. 2024;49:1163\u201374. https:\/\/doi.org\/10.1139\/apnm-2024-0037.","journal-title":"Appl Physiol Nutr Metab"},{"key":"729_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1476-5381.2010.00789.x","volume":"161","author":"AB Cadwallader","year":"2010","unstructured":"Cadwallader AB, De La Torre X, Tieri A, Botr\u00e8 F. The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis. Br J Pharmacol Wiley. 2010;161:1\u201316. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00789.x.","journal-title":"Br J Pharmacol Wiley"},{"key":"729_CR63","doi-asserted-by":"publisher","unstructured":"Patel AJ, Tejera S, Klek SP, Rothberger GD, Elsevier BV. 2020;6:e252\u20136. https:\/\/doi.org\/10.4158\/accr-2020-0154","DOI":"10.4158\/accr-2020-0154"},{"key":"729_CR64","doi-asserted-by":"publisher","DOI":"10.12890\/2021_002362","author":"Q Van Bokhorst","year":"2021","unstructured":"Van Bokhorst Q, Krul-Poel Y, Smit D, De Ronde W. A 29-year-old Bodybuilder with Liothyronine-induced Thyrotoxic Hypokalaemic Periodic Paralysis. Eur J Case Rep Intern Med [Internet] SMC Media. 2021. https:\/\/doi.org\/10.12890\/2021_002362. [cited 2026 Apr 2];8.","journal-title":"Eur J Case Rep Intern Med [Internet] SMC Media"},{"key":"729_CR65","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.3390\/ijerph19074288","volume":"19","author":"V Tidmas","year":"2022","unstructured":"Tidmas V, Brazier J, Hawkins J, Forbes SC, Bottoms L, Farrington K. Nutritional and Non-Nutritional Strategies in Bodybuilding: Impact on Kidney Function. Int J Environ Res Public Health MDPI AG. 2022;19:4288. https:\/\/doi.org\/10.3390\/ijerph19074288.","journal-title":"Int J Environ Res Public Health MDPI AG"},{"key":"729_CR66","doi-asserted-by":"publisher","unstructured":"Bernet VJ. Thyroid hormone misuse and abuse. Endocrine. Springer Science and Business, Media LLC. 2019;66:79\u201386. https:\/\/doi.org\/10.1007\/s12020-019-02045-1","DOI":"10.1007\/s12020-019-02045-1"},{"key":"729_CR67","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ando.2023.03.008","volume":"84","author":"L Persani","year":"2023","unstructured":"Persani L, dell\u2019Acqua M, Ioakim S, Campi I. Factitious thyrotoxicosis and thyroid hormone misuse or abuse. Ann Endocrinol Elsevier BV. 2023;84:367\u20139. https:\/\/doi.org\/10.1016\/j.ando.2023.03.008.","journal-title":"Ann Endocrinol Elsevier BV"},{"key":"729_CR68","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2024-0139","author":"A Nappi","year":"2024","unstructured":"Nappi A, Moriello C, Morgante M, Fusco F, Crocetto F, Miro C. Effects of thyroid hormones in skeletal muscle protein turnover. Walter de Gruyter GmbH; 2024. [cited 2026 Apr 2]. https:\/\/doi.org\/10.1515\/jbcpp-2024-0139. J Basic Clin Physiol Pharmacol [Internet]."},{"key":"729_CR69","doi-asserted-by":"publisher","DOI":"10.1530\/edm-21-0060","author":"CE Bonnar","year":"2021","unstructured":"Bonnar CE, Brazil JF, Okiro JO, Giblin L, Smyth Y, O\u2019Shea PM, et al. Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder. Endocrinol Diabetes Metab Case Rep [Internet] Bioscientifica. 2021. https:\/\/doi.org\/10.1530\/edm-21-0060. [cited 2026 Apr 2];2021.","journal-title":"Endocrinol Diabetes Metab Case Rep [Internet] Bioscientifica"},{"key":"729_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1059473","author":"P Bond","year":"2022","unstructured":"Bond P, Smit DL, De Ronde W. Anabolic\u2013androgenic steroids: How do they work and what are the risks? Front Endocrinol [Internet]. Front Media SA. 2022. https:\/\/doi.org\/10.3389\/fendo.2022.1059473. [cited 2026 Apr 2];13.","journal-title":"Front Media SA"},{"key":"729_CR71","doi-asserted-by":"publisher","first-page":"102215","DOI":"10.1016\/j.rpth.2023.102215","volume":"7","author":"E Camilleri","year":"2023","unstructured":"Camilleri E, Smit DL, Van Rein N, Le Cessie S, De Hon O, Den Heijer M, et al. Coagulation profiles during and after anabolic androgenic steroid use: data from the HAARLEM study. Res Pract Thromb Haemost Elsevier BV. 2023;7:102215. https:\/\/doi.org\/10.1016\/j.rpth.2023.102215.","journal-title":"Res Pract Thromb Haemost Elsevier BV"},{"key":"729_CR72","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00228-023-03592-3","volume":"80","author":"N Leciejewska","year":"2024","unstructured":"Leciejewska N, J\u0119drejko K, G\u00f3mez-Renaud VM, Manr\u00edquez-N\u00fa\u00f1ez J, Muszy\u0144ska B, Pokrywka A. Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases. Eur J Clin Pharmacol Springer Sci Bus Media LLC. 2024;80:185\u2013202. https:\/\/doi.org\/10.1007\/s00228-023-03592-3.","journal-title":"Eur J Clin Pharmacol Springer Sci Bus Media LLC"},{"key":"729_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1634799","author":"P Bond","year":"2025","unstructured":"Bond P, Smit DL, Verdegaal T, De Ronde W. Selective androgen receptor modulators: a critical appraisal. Front Endocrinol [Internet] Front Media SA. 2025. https:\/\/doi.org\/10.3389\/fendo.2025.1634799. [cited 2026 Apr 2];16.","journal-title":"Front Endocrinol [Internet] Front Media SA"},{"key":"729_CR74","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1177\/03635465241252435","volume":"53","author":"N Vasireddi","year":"2025","unstructured":"Vasireddi N, Hahamyan HA, Gould HP, Gregory AJM, Gausden EB, Dodson CC, et al. Athlete Selective Androgen Receptor Modulators Abuse: A Systematic Review. Am J Sports Med SAGE Publications. 2025;53:999\u20131009. https:\/\/doi.org\/10.1177\/03635465241252435.","journal-title":"Am J Sports Med SAGE Publications"},{"key":"729_CR75","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1093\/eurheartj\/ehaf285","volume":"46","author":"M Vecchiato","year":"2025","unstructured":"Vecchiato M, Ermolao A, Da Col M, Aghi A, Berton G, Palermi S, et al. Mortality in male bodybuilding athletes. Eur Heart J Oxf Univ Press (OUP). 2025;46:3006\u201316. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf285.","journal-title":"Eur Heart J Oxf Univ Press (OUP)"},{"key":"729_CR76","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/nyas.15187","volume":"1538","author":"B Grant","year":"2024","unstructured":"Grant B, Hyams E, Davies R, Minhas S, Jayasena CN. Androgen abuse: Risks and adverse effects in men. Ann N Y Acad Sci Wiley. 2024;1538:56\u201370. https:\/\/doi.org\/10.1111\/nyas.15187.","journal-title":"Ann N Y Acad Sci Wiley"},{"key":"729_CR77","unstructured":"U.S. Food & Drug Administration (FDA). FDA\u2019s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. US Food Drug Adm. FDA. FDA. 2026. Accessed 2 Apr 2026. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss. [cited 2026 Apr 2]."},{"key":"729_CR78","unstructured":"U.S. Food & Drug Administration (FDA). FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain. US Food Drug Adm. FDA. FDA; 2025. Accessed 2 Apr 2026. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain. [cited 2026 Apr 2]."},{"key":"729_CR79","unstructured":"World Health Organization (WHO). Medical Product Alert N\u00b02\/2024: Falsified OZEMPIC (semaglutide) [Internet]. World Health Organ. WHO. Accessed 2 Apr 2026. https:\/\/www.who.int\/news\/item\/19-06-2024-medical-product-alert-n-2-2024--falsified-ozempic-(semaglutide). [cited 2026 Apr 2]."},{"key":"729_CR80","unstructured":"Research C, for DE. and. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. FDA. 2024. Accessed 2 Apr 2026. https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded. [cited 2026 Apr 2]."},{"key":"729_CR81","unstructured":"Makary MA. FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs. US Food Drug Adm. FDA. FDA; 2026. Accessed 2 Apr 2026. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-intends-take-action-against-non-fda-approved-glp-1-drugs. [cited 2026 Apr 2]."},{"key":"729_CR82","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1097\/hjh.0000000000000145","volume":"32","author":"J Jordan","year":"2014","unstructured":"Jordan J, Astrup A, Engeli S, Narkiewicz K, Day WW, Finer N. Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity. J Hypertens Ovid Technol (Wolters Kluwer Health). 2014;32:1178\u201388. https:\/\/doi.org\/10.1097\/hjh.0000000000000145.","journal-title":"J Hypertens Ovid Technol (Wolters Kluwer Health)"},{"key":"729_CR83","doi-asserted-by":"publisher","first-page":"799","DOI":"10.30773\/pi.2023.0045","volume":"20","author":"E Kim","year":"2023","unstructured":"Kim E, Rim D, Shin J-H, Wong D, Kim DW. The Use of Phentermine for Obesity in Psychiatric Patients With Antipsychotics. Psychiatry Investig Korean Neuropsychiatric Association. 2023;20:799\u2013807. https:\/\/doi.org\/10.30773\/pi.2023.0045.","journal-title":"Psychiatry Investig Korean Neuropsychiatric Association"},{"key":"729_CR84","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/08897077.2013.772083","volume":"34","author":"HA Spiller","year":"2013","unstructured":"Spiller HA, James KJ, Scholzen S, Borys DJ. A Descriptive Study of Adverse Events from Clenbuterol Misuse and Abuse for Weight Loss and Bodybuilding. Subst Abuse SAGE Publications. 2013;34:306\u201312. https:\/\/doi.org\/10.1080\/08897077.2013.772083.","journal-title":"Subst Abuse SAGE Publications"},{"key":"729_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1214374","author":"K Fadah","year":"2023","unstructured":"Fadah K, Gopi G, Lingireddy A, Blumer V, Dewald T, Mentz RJ. Anabolic androgenic steroids and cardiomyopathy: an update. Front Cardiovasc Med [Internet] Front Media SA. 2023. https:\/\/doi.org\/10.3389\/fcvm.2023.1214374. [cited 2026 Apr 2];10.","journal-title":"Front Cardiovasc Med [Internet] Front Media SA"}],"container-title":["Current Obesity Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00729-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13679-026-00729-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00729-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:48:08Z","timestamp":1781232488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13679-026-00729-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["729"],"URL":"https:\/\/doi.org\/10.1007\/s13679-026-00729-0","relation":{"references":[{"id-type":"doi","id":"10.1515\/jbcpp-2024-0139","asserted-by":"subject"}]},"ISSN":["2162-4968"],"issn-type":[{"value":"2162-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}